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CDK inhibitors (p16/p19/p21) induce senescence
and autophagy in cancer-associated fibroblasts,
“fueling” tumor growth via paracrine interactions,
without an increase in neo-angiogenesis
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Here, we investigated the compartment-specific role of cell cycle arrest and senescence in breast cancer tumor growth.
For this purpose, we generated a number of hTERT-immortalized senescent fibroblast cell lines overexpressing CDK
inhibitors, such as p16(INK4A), p19(ARF) or p21(WAF1/CIP1). Interestingly, all these senescent fibroblast cell lines showed
evidence of increased susceptibility toward the induction of autophagy (either at baseline or after starvation), as well as
significant mitochondrial dysfunction. Most importantly, these senescent fibroblasts also dramatically promoted tumor
growth (up to ~2-fold), without any comparable increases in tumor angiogenesis. Conversely, we generated human breast
cancer cells (MDA-MB-231 cells) overexpressing CDK inhibitors, namely p16(INK4A) or p21(WAF1/CIP1). Senescent MDAMB-231 cells also showed increased expression of markers of cell cycle arrest and autophagy, including β-galactosidase, as
predicted. Senescent MDA-MB-231 cells had retarded tumor growth, with up to a near 2-fold reduction in tumor volume.
Thus, the effects of CDK inhibitors are compartment-specific and are related to their metabolic effects, which results in
the induction of autophagy and mitochondrial dysfunction. Finally, induction of cell cycle arrest with specific inhibitors
(PD0332991) or cellular stressors [hydrogen peroxide (H2O2) or starvation] indicated that the onset of autophagy and
senescence are inextricably linked biological processes. The compartment-specific induction of senescence (and hence
autophagy) may be a new therapeutic target that could be exploited for the successful treatment of human breast cancer
patients.

Introduction
The exact functional relationship between cell cycle arrest,
senescence and autophagy remains unknown.1-9 Both senescence and autophagy are thought to play key mechanistic
roles in the development of multiple aging-associated diseases,
and especially human cancers.10,11 Thus, understanding senescence and autophagy has wide clinical implications, for both
regenerative medicine and cancer prevention. Two relevant
mechanistic questions are: (1) Is autophagy sufficient to induce
senescence? and, conversely, (2) Is senescence sufficient to
induce autophagy?

Recent studies have shown that senescence and autophagy
may be part of the same metabolic program, known as the
autophagy-senescence transition (AST).10-21 In support of this
notion, recombinant expression of autophagy genes (BNIP3,
Cathepsin B or ATG16L1) in stromal fibroblasts is sufficient to
induce the onset of constitutive autophagy as well as the development of senescence.12,13 In this model, “leaky” lysosomes
drive the onset of aging and senescence in response to cellular
stress.22,23 Thus, autophagy is indeed sufficient to induce senescence.22,23 The AST also leads to mitophagy, due to the onset of
mitochondrial dysfunction, resulting in a cellular shift toward
aerobic glycolysis and ketone production.12,13 Importantly, these
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sufficient to induce autophagy and to drive the onset of mitophagy,
as well as mitochondrial dysfunction. Thus, we validated the existence of the senescence-autophagy transition (SAT). Importantly,
these CDK-overexpressing fibroblasts also significantly promoted
tumor growth, without an increase in angiogenesis.
As such, our current results provide a new genetically tractable
model for understanding the metabolic role of “host aging” in
promoting tumor growth and metastasis by providing a “fertile,”
local microenvironment.
Conversely, overexpression of CDK-inhibitor proteins in
breast cancer cells resulted in reduced tumor growth, secondary
to the induction of autophagy in tumor cells. This may provide
an innovative targeted approach for new avenues of therapeutic
intervention.
Finally, using a pharmacological approach relying on specific
inhibitors (PD0332991) and cellular stressors (hydrogen peroxide or starvation), we show that autophagy and senescence are
two closely linked biological phenomena, implying that they are
part of the same coordinated metabolic program.
Results
Figure 1. Treatment with PD0332991, a CDK4/6-inhibitor, induces markers of senescence and autophagy. hTERT-BJ1 fibroblasts were incubated with PD0332991 (0.1, 0.5 and 1 μM) for 36 h before the cells were
harvested and subjected to immunoblot analysis with specific antibody
probes. Note that PD0332991 effectively inhibits the phosphorylation
of RB, as predicted. In addition, PD0332991 induces the upregulation of three markers of senescence [p21(WAF1/CIP1), p16(INK4A) and
β-galactosidase]. Similarly, LC3 expression (an autophagy marker) is
progressively upregulated. Blotting with β-actin is shown as a control
for equal protein loading.

autophagic-senescent fibroblasts undergo catabolism and locally
produce high-energy mitochondrial fuels (such as L-lactate,
ketone bodies and glutamine).12,13 These mitochondrial fuels can
then act as onco-catabolites, driving anabolic tumor growth and
cancer cell metastasis.24-36 This simple energy-transfer mechanism may also be very important for tumor initiation, especially
under conditions where tumor angiogenesis has yet to occur, providing a “fertile ground” for tumor growth.37-42
However, it remains unknown if cell cycle arrest and senescence are also sufficient to drive the onset of autophagy, resulting
in the senescence-autophagy transition (SAT). If this was indeed
the case, then the SAT would explain why chronological aging
is one of the single most important risk factors for the development of human cancers. It would establish, unequivocally, that
chronological aging directly generates high-energy nutrients
(onco-catabolites) to “feed” cancer cells.
Here, we used a genetic approach to test the hypothesis that cell
cycle arrest and senescence were sufficient to induce an autophagic phenotype in cancer-associated fibroblasts. To test this idea,
we created a panel of hTERT-immortalized fibroblast cell lines
that recombinantly overexpress well-known CDK inhibitors,
such as p16(INK4A), p19(ARF), smARF and p21(WAF1/CIP1).
Interestingly, overexpression of CDK-inhibitor proteins was
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Cell cycle arrest, autophagy and senescence are three closely
linked biological processes. To experimentally assess the relationship between cell cycle arrest, senescence and autophagy, we
first used a pharmacological approach to induce cell cycle arrest
with the CDK4/6 chemical inhibitor, PD0332991.43,44 For this
purpose, hTERT-immortalized fibroblasts were treated with
PD0332991 (0.1, 0.5 and 1 μM) for a period of 36 h, and then
the cells were subjected to biochemical analysis.
Figure 1 shows that treatment with PD0332991 dramatically
inhibits RB-phosphorylation, as expected, resulting in the upregulation of markers of cell cycle arrest, such as CDK inhibitors
(p16 and p21), as well as markers of senescence (β-galactosidase)
and autophagy (LC3-I/II). Thus, the induction of cell cycle
arrest is closely linked to the onset of senescence and autophagy.
Next, we assessed the response to a well-established cellular
stress, hydrogen peroxide (H2O2; 300 μM), which is known to
induce oxidative stress, senescence and autophagy. Then, we followed changes in markers of the cell cycle and autophagy, over a
time course of 8 d post-treatment. Figure 2A shows that H202treatment induces the upregulation of markers of cell cycle arrest
and senescence (p53, p21, β-galactosidase), as well the downregulation of markers of cell proliferation (phospho-RB, PCNA),
within the first 2–3 d post-treatment. Figure 2B indicates that
H2O2 treatment induces a panel of lysosomal (Lamp-1, cathepsin B) and autophagy/mitophagy markers (Beclin-1, BNIP3,
LC3-I/II) within 4–6 d post-treatment.
Finally, we determined the response to another cellular stress
closely associated with autophagy, i.e., amino acid starvation. A
preliminary time course study indicated that autophagy peaked
at 3 h and cell cycle arrest peaked at 4 h. Figure 3 (left panel)
shows that at 3 h post-starvation, several markers of autophagy (Lamp-1, BNIP3 and LC3) are upregulated. Similarly,
Figure 3 (right panel) illustrates that at 4 h post-starvation, a panel
of markers associated with cell cycle arrest and senescence (p16,
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Figure 2. Acute treatment with hydrogen peroxide (H2O2) induces markers of senescence and autophagy. hTERT-BJ1 fibroblasts were treated for 1 h
with H2O2 (300 μM) and then cultured for 0–8 d. Then, at each time point, the cells were harvested and subjected to immunoblot analysis. Blotting
with β-actin is shown as a control for equal protein loading. (A) Markers of the cell cycle and senescence. Note that several markers of cell cycle arrest
and senescence were increased at days 2 and 3 post-treatment [p53, p21(WAF1/CIP1) and β-galactosidase], while markers of cell cycle progression
are decreased (phospho-RB and PCNA). (B) Markers of autophagy and mitophagy. Note that several markers of autophagy, mitophagy and lysosomes
(Lamp-1, Beclin-1, BNIP3, cathepsin B and LC3) were increased, mainly at days 4–6 post-treatment.

p19, p21, p53, β-galactosidase) are all upregulated. Conversely, at
the same time point, markers of cell proliferation are downregulated (phospho-RB and cyclin D1).
In summary, based on this analysis, we conclude that cell
cycle arrest, autophagy and senescence are three closely linked
conserved biological processes, such that autophagy induces
senescence and, conversely, senescence induces autophagy.
p19(ARF) and smARF drive the onset of senescence and
autophagy in cancer-associated fibroblasts, metabolically
promoting tumor growth, without increased angiogenesis.
p19(ARF) and its closely related truncated isoform, smARF, are
best known to function as CDK inhibitors.45-51 To study the potential metabolic effects of p19(ARF) and smARF, they were both
stably expressed in hTERT-immortalized fibroblasts. Figure 4A
indicates that we successfully generated stable cell lines expressing either p19(ARF) or smARF. Since they are both continuously
degraded by the proteasomal machinery, we used treatment with
the proteasomal-inhibitor MG-132 (10 μM for 16 h) to facilitate
their detection. In addition, Figure 4B indicates that p19(ARF)and smARF-expressing fibroblasts are more susceptible to the
induction of p16 and p21 under conditions of H2O2 exposure,
as expected. Under these conditions (Fig. 4C), we also observed
a loss of Cav-1 expression, suggesting its lysosomal degradation
by autophagy.
To validate the hypothesis that both smARF and p19(ARF)
expression increase the susceptibility to autophagy, these stable
fibroblast cell lines were acutely treated with H2O2 and cultured
for an additional 5 d to allow the onset of senescence. Figure 5
shows that the expression of either smARF or p19(ARF) increases
the levels of a panel of autophagy markers (Lamp-1, Beclin-1,
BNIP3, cathepsin B, LC3 and legumain), in accordance with our
hypothesis.
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Figure 3. Acute starvation induces markers of autophagy and senescence. After 3 h of acute starvation with Hepes-buffered HBSS, several
markers of autophagy were increased (Lamp-1, BNIP3, LC3). Similarly,
after 4 h of acute starvation with HBSS, a panel of markers for cell cycle
arrest [p21(WAF1/CIP1), p19(ARF), p16(INK4A), p53, β-galactosidase]
were all increased. Conversely, markers of cell cycle progression were
significantly decreased (phospho-RB and cyclin D1). Blotting with
β-actin is shown as a control for equal protein loading.

We further validated that that both smARF- and p19(ARF)expressing fibroblasts are more susceptible to the onset of H2O2induced senescence, using β-galactosidase as a marker. Figure 6
shows representative images and corresponding quantitation,
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Figure 5. Both smARF and p19(ARF) expression increases the susceptibility of fibroblasts to the onset of autophagy. Stable fibroblast cell
lines were acutely treated with H2O2 and cultured for an additional 5 d.
Then, the expression of autophagy markers was assessed. Note that the
expression of either smARF or p19(ARF) increases the levels of a panel
of autophagy markers (Lamp-1, Beclin-1, BNIP3, cathepsin B, LC3 and
legumain). Blotting with β-actin is shown as a control for equal protein
loading.

Figure 4. Generating stable fibroblast cell lines which constitutively
express smARF and p19(ARF). hTERT-BJ1 fibroblasts were transduced
with lenti-viral vectors encoding smARF or p19(ARF) and then selected
for puromycin-resistance. Control fibroblasts transduced with the
empty vector (EV; Lv-105) were produced in parallel. Then, these stable
cell lines were subjected to biochemical analysis. Blotting with β-actin
is shown as a control for equal protein loading. (A) Treatment with the
proteasome inhibitor MG-132. After overnight treatment (16 h) with
MG-132 (10 μM), the cells were harvested and subjected to immunoblot
analysis. Note that both smARF and p19(ARF) were stably expressed.
(B) Acute treatment with H2O2. After acute treatment with H2O2 (300
μM), the fibroblasts were cultured for an additional 5 d to allow the
onset of senescence. Note that fibroblasts transduced with smARF or
p19(ARF) show the upregulation of p16(INK4A) and/or p21 (WAF1/CIP1),
other CDK inhibitors. (C) As in (B), except the expression of Cav-1 was
assessed. Note the 2-fold reduction in Cav-1 expression.

indicating that smARF and p19(ARF) expression increase
β-galactosidase positivity by > 3-fold. In addition, under conditions of hypoxia, p19(ARF) also induces a > 2-fold increase in
L-lactate production, consistent with the onset of mitophagy and
mitochondrial dysfunction (Fig. 7). Thus, p19(ARF)-induced
cell cycle arrest increases the susceptibility of cells toward the
onset of stress-induced cellular senescence, resulting in the activation of autophagic processes and a metabolic shift toward
glycolysis.
Most importantly, fibroblasts overexpressing smARF or
p19(ARF) effectively promoted tumor growth (Fig. 8). Stable
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fibroblast cell lines were co-injected with MDA-MB-231(GFP)
breast cancer cells into the flanks of immunodeficient mice.
Then, tumor growth was followed for a period of 30 d postinjection. Figure 8A and B show that fibroblasts overexpressing
smARF or p19(ARF) resulted in a near 2-fold increase in tumor
growth. However, CD31 immunostaining indicated that angiogenesis could not account for the observed increase in tumor
growth (Fig. 8C).
p16(INK4A) and p21(WAF1/CIP1) induce senescence and
autophagy in cancer-associated fibroblasts, metabolically promoting tumor growth, without increased angiogenesis. To further assess the relationship between cell cycle arrest, autophagy
and senescence, we next focused on the metabolic effects of
two other well-known CDK inhibitors, namely p16(INK4A)
and p21(WAF1/CIP1). For this purpose, we generated hTERT
fibroblast cell lines overexpressing p16(INK4A) and p21(WAF1/
CIP1). Figure 9 directly shows that p16(INK4A) and p21(WAF1/
CIP1) were effectively stably expressed in hTERT-BJ1 cells. As
predicted, this resulted in the corresponding upregulation of a
panel of markers of cell cycle arrest and senescence (p16, p21, p53
and β-galactosidase).
In further support of the notion that senescence and autophagy are part of the same metabolic program, Figure 10 shows that
p16(INK4A)- and p21(WAF1/CIP1)-expressing fibroblasts are
more autophagic, both at baseline and under conditions of starvation (Fig. 10A and B), and they also show a tendency toward cell
hypertrophy, consistent with a senescent phenotype (Fig. 10C).
Overexpression of markers of autophagy (Lamp-1 and BNIP3)
is observed, especially in cells overexpressing p21(WAF1/CIP1).
Similarly, after 12 h of starvation in Hepes-buffered HBSS,
the overexpression of markers of autophagy (LC3-I/II) is
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Figure 6. Both smARF and p19(ARF) expression increases the susceptibility of fibroblasts to the onset of senescence. Stable fibroblast cell
lines were acutely treated with H2O2 and cultured for an additional 5 d.
Then, the expression of β-galactosidase activity was assessed. Note that
the expression of either smARF or p19(ARF) increases β-galactosidase
activity by ~3-fold. Representative images are shown in (A), and quantitation is presented in (B).

Figure 7. p19(ARF) increases L-lactate production. Stable fibroblast cell
lines were subjected to chronic hypoxia for 48 h. Then, the levels of Llactate that accumulated in the tissue-culture media were assessed and
normalized to the amount of total cellular protein. Note that p(19)ARF
expression increases L-lactate accumulation by > 2-fold.

detected, especially in cells overexpressing p21(WAF1/CIP1).
However, cell hypertrophy is observed most significantly in fibroblasts overexpressing p16(INK4A).
As strong BNIP3 overexpression was observed in p16- and
p21-overexpressing fibroblasts, and BNIP334,52-55 is associated
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Figure 8. Fibroblasts overexpressing smARF or p19(ARF) promote tumor growth. Stable fibroblast cell lines were co-injected with MDA-MB231(GFP) breast cancer cells into the flanks of immunodeficient mice.
Then, tumor growth was followed for a period of 30 d post-injection. (A)
shows the time course of tumor growth and (B) shows the final tumor
volume at sacrifice, which resulted in a near 2-fold increase in tumor
growth. (C) shows the results CD31 immunostaining, indicating that angiogenesis cannot account for the observed increase in tumor growth.

with mitophagy and mitochondrial dysfunction, we assessed the
status of mitochondrial oxidative phosphorylation (OXPHOS).
Figure 11 shows that fibroblasts overexpressing p16(INK4A)
and p21(WAF1/CIP1) both show significant changes in mitochondrial OXPHOS components. Importantly, dramatic reductions in several OXPHOS complex components was observed,
especially complex I, III and V. Similarly, reductions were also
observed in complex II and IV, but to a lesser extent. This is

Cell Cycle

3603

Figure 9. Generating stable fibroblast cell lines, which constitutively
express p16(INK4A) and p21(WAF1/CIP1). hTERT-BJ1 fibroblasts were
transduced with lenti-viral vectors encoding p16(INK4A) and p21(WAF1/
CIP1) and then selected for puromycin-resistance. Control fibroblasts
transduced with the empty vector (EV; Lv-105) were produced in
parallel. Then, these stable cell lines were subjected to biochemical
analysis. Note that after 6 d of culture, the overexpression of markers of
cell cycle arrest and senescence [p16(INK4A, p21(WAF1/CIP1), p53 and
β-galactosidase] is observed. Blotting with β-actin is shown as a control
for equal protein loading.

consistent with mitochondrial dysfunction and a shift toward
glycolysis.
We also determined the tumor-promoting activity of p16- and
p21-senescent fibroblasts. These stable fibroblast cell lines were
co-injected with MDA-MB-231(GFP) breast cancer cells into the
flanks of immunodeficient mice. Then, tumor growth was followed for a period of 4 wk post-injection. Figure 12A shows the
final tumor volume at sacrifice, which resulted in a near 2-fold
increase in tumor growth. Figure 12B illustrates that tumorassociated CD31 immunostaining is not elevated, indicating that
angiogenesis does account for the increased tumor growth. Thus,
senescent-autophagic fibroblasts promote tumor growth, independently of neo-angiogenesis.
p16(INK4A) and p21(WAF1/CIP1) induce senescence
and autophagy in breast cancer cells, metabolically inhibiting tumor growth. To examine the compartment-specific
effects of senescence and autophagy on tumor growth, we also
created MDA-MB-231 breast cancer cell lines overexpressing p16(INK4A) and p21(WAF1/CIP1). Figure 13 shows that
we successfully generated MDA-MB-231 breast cancer cells
overexpressing p16 or p21, which resulted in the induction of
β-galactosidase, an established marker of cell cycle arrest and
senescence.
Morphologically, MDA-MB-231 cells overexpressing
p16(INK4A) and p21(WAF1/CIP1) also appeared more hypertrophic and expressed increased β-galactosidase activity, consistent with a senescence phenotype (Fig. 14).
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Figure 10. Stable fibroblast cell lines, which constitutively express
p16(INK4A) and p21(WAF1/CIP1), show the onset of increased autophagy and/or cell hypertrophy. (A) Autophagy at baseline. Note that after 6
d of culture, the overexpression of markers of autophagy (Lamp-1 and
BNIP3) is observed, especially in cells overexpressing p21(WAF1/CIP1).
Blotting with β-actin is shown as a control for equal protein loading. (B)
Autophagy after starvation. Note that after 12 h of starvation in Hepesbuffered HBSS, the overexpression of markers of autophagy (LC3-I/II) is
observed, especially in cells overexpressing p21(WAF1/CIP1). Blotting
with β-actin is shown as a control for equal protein loading. (C) Cell hypertrophy. Note that after 2 d of culture, cell hypertrophy is observed,
especially in cells overexpressing p16(INK4A).

Figure 15 illustrates that MDA-MB-231 cells, which overexpress p16(INK4A) and p21(WAF1/CIP1), undergo increased
authophagy, either at baseline (Lamp-1, BNIP3, LC3-I/II) or
under conditions of starvation for 12 h with HBSS (Beclin-1, and
cathepsin B). Therefore, cell cycle arrest, senescence and autophagy in cancer cells are all part of the same metabolic program.
Most importantly, MDA-MB-231 cells, which overexpress
p16(INK4A) and p21(WAF1/CIP1), show a near 2-fold reduction in tumor volume. Thus, senescence and autophagy in cancer
cells metabolically inhibits tumor growth.
Discussion
Here, we investigated the existence of the senescence-autophagy
transition (SAT), using a molecular genetic approach (Fig. 16).
More specifically, we tested the hypothesis that chronological
aging may facilitate the growth of tumors via the onset of cell cycle
arrest and senescence, which, in turn, drives the induction of an
autophagic program in stromal fibroblasts. Senescence-induced
autophagy would provide a “fertilized” microenvironment to
facilitate the growth of cancer cells via the paracrine production
of high-energy mitochondrial fuels (such L-lactate) that can then
function as onco-catabolites.41,42,56-60 These recycled nutrients
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Figure 12. Fibroblasts overexpressing p16(INK4A) and p21(WAF1/CIP1) promote tumor growth in a paracrine fashion. Stable fibroblast cell lines were
co-injected with MDA-MB-231(GFP) breast cancer cells into the flanks of immunodeficient mice. Then, tumor growth was followed for a period of 4
wk post-injection. (A) shows the final tumor volume at sacrifice, which resulted in a near 2-fold increase in tumor growth. (B) shows the results CD31
immunostaining, indicating that angiogenesis cannot account for the observed increase in tumor growth.

promote anabolic tumor growth by increasing mitochondrial
metabolism (OXPHOS) in adjacent cancer cells.31-34,37-40,61-63
To test this hypothesis, we created a variety of hTERT-immortalized fibroblast cell lines stably overexpressing established CDKinhibitor proteins, such as p16(INK4A), p19(ARF), smARF and
p21(WAF1/CIP1). Importantly, these cell lines overexpressing
CDK inhibitors were clearly more sensitive to the induction of
senescence and autophagy, especially under conditions of stress,
such as hydrogen peroxide exposure and/or starvation. These
CDK-inhibitor overexpressing cell lines also showed evidence
of mitochondrial dysfunction, such as either increased L-lactate
production or reductions in mitochondrial OXPHOS complexes
as well as the upregulation of mitophagy markers, such as BNIP3.
Thus, it appears that senescence and autophagy are two related
faces of the same metabolic aging-associated program.
Interestingly, these CDK-inhibitor-overexpressing fibroblast
cell lines also significantly promoted tumor growth, by up to
2-fold, without any significant increases in neo-angiogenesis.
Thus, senescent-autophagic fibroblasts have tumor growth-promoting properties. Conversely, CDK-inhibitor protein expression
in breast cancer cells significantly retarded tumor growth and was
associated with the induction of markers of senescence, autophagy and mitophagy in these epithelial cancer cells.
Pharmacological induction of cell cycle arrest, by using a
chemical CDK4/6 inhibitor (PD0332991) or use of other relevant cellular stressors (hydrogen peroxide and starvation), all
had the same net effect, resulting in the induction of molecules
associated both with senescence and autophagy. Thus, we have
unequivocally established that these two biological processes are
tightly linked.
Several previous studies have also highlighted the tumor-promoting properties of senescent fibroblasts.9,64-66 For example, Dr.
Judy Campisi’s group has shown that senescent fibroblasts directly
promote tumor growth via the increased secretion of cytokines
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Figure 11. Fibroblast cell lines, which constitutively express p16(INK4A)
and p21(WAF1/CIP1), show significant reductions in OXPHOS complex
components. Note that after 6 d of culture, dramatic reductions in
OXPHOS complex components is observed, especially complex I, III and
V. Reductions were also observed in complex II and IV, but to a lesser
extent. Blotting with β-actin is shown as a control for equal protein
loading.

and chemokines.9,64-66 This is known as SASP, the senescenceassociated secretory phenotype. However, Dr. Campisi’s group
has also shown that SASP is actually not required for the tumorpromoting activity of senescent fibroblasts,64 implying the existence of another related or independent paracrine mechanism.
Thus, the senescence-autophagy transition (SAT) may represent
another mechanism by which senescent fibroblasts effectively
promote tumor growth.
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previous studies have shown that tumor
cells induce the activation of NFκB in
cancer-associated fibroblasts via oxidative
stress, resulting in cytokine production and
a shift toward autophagy and glycolytic
metabolism.24,30,34,35,67,68 This is essentially
the same phenotype as the SASP and SAT,
as oxidative stress is a strong inducer of both
senescence and autophagy. In fact, increased
protein synthesis and the secretion of cytokines are known to occur during autophagy
as a protective response against excessive
protein degradation and apoptosis.11,69
Our current studies on the tumorpromoting effects of p16(INK4A) fibroblasts may also explain recent biomarker
data showing that an increase in stromal
p16(INK4A) levels in human DCIS lesions
(a precursor to full-blown breast cancer)
dramatically increases the hazard ratio for
recurrence by nearly 9-fold (p < 0.0001).70
Figure 14. MDA-MB-231 breast cancer cell lines, which overexpress p16(INK4A) and p21(WAF1/
Thus, senescent-autophagic fibroblasts may
CIP1), show signs of senescence. (A) Cell hypertrophy. MDA-MB-231 cells, which overexpress
p16(INK4A) and p21(WAF1/CIP1), morphologically appear flatter or hypertrophic. Representabe critical for “fueling” tumor initiation,
tive phase images are shown. (B) Beta-galactosidase. MDA-MB-231 cells, which overexpress
progression and cancer recurrence. As such,
p16(INK4A) and p21(WAF1/CIP1), also appear to have increased β-galactosidase activity.
our findings have important clinical and
translational implication for future biomarker discovery and treatment stratification in DCIS and breast
cancer patients.
Materials and Methods

Figure 13. Generating MDA-MB-231 breast cancer cell lines, which
overexpress p16(INK4A) and p21(WAF1/CIP1). MDA-MB-231(GFP) cells
were transduced with lenti-viral vectors encoding p16(INK4A) and
p21(WAF1/CIP1), and then selected for puromycin-resistance. Control
cells transduced with the empty vector (EV; Lv-105) were produced in
parallel. Then, these stable cell lines were subjected to biochemical
analysis. Note the overexpression of markers of cell cycle arrest and senescence [p16(INK4A, p21(WAF1/CIP1) and β-galactosidase] is observed.
Blotting with β-actin is shown as a control for equal protein loading.

These two seemingly unrelated mechanisms may also be
intimately linked, as NFκB is both a master regulator of cytokine production, and its activation is required for the induction
of autophagy. Thus, activation of NFκB in cancer-associated
fibroblasts could account for both the SASP and SAT. In fact,

3606

Materials. Commercially available antibodies used were as follows: β-actin (Sigma-Aldrich, #A5441); Cav-1 mAb 2297
(BD Transduction Laboratories, #610406); Beclin1 (Novus
Biologicals, #NBP1-00085); BNIP3 (Abcam, #ab10433);
BNIP3L (Abcam, #ab8399); Beta-galactosidase (GLB1; Abcam,
#ab55176); p53 (Ab-6; Calbiochem, #OP43); Cathepsin B
(FL-339) (Santa Cruz, #sc-13985); Lamp-1 (E-5) (Santa Cruz,
#sc-17768); LC3B (Abcam, #ab48394); legumain (Santa Cruz,
#sc-67163); p21 (H-164 or F-5) (Santa Cruz, #sc-756 or #sc6246); p19 (DCS-240) (Santa Cruz, #sc-53639); p16 (H-156)
(Santa Cruz, #sc-759); cyclin D1 (Thermo Scientific, #MS-210)
and OXPHOS (MitoSciences, #MS601). Lenti-viral vectors
containing full-length cDNAs encoding various CDK-inhibitor
genes [p16(INK4A), p19(ARF) and p21(WAF1/CIP1)] were all
obtained commercially from GeneCopoeia. PD0332991 (the
specific CDK4/6-inhibitor; #S1116) was obtained from Selleck
Chemicals, Inc.
Cell culture. Immortalized human fibroblasts (hTERT-BJ1
cells) and human breast cancer cells (MDA-MB-231-GFP) were
cultured in DMEM implemented with 10% fetal bovine serum
(FBS) and penicillin (100 units/mL)/streptomycin (100 μg/mL)
(P/S). Hank’s balanced salt solution (HBSS), supplemented with
40 mM Hepes and 1% P/S, was used to initiate cell starvation.
For co-culture studies, hTERT fibroblasts and MDA-MB-231GFP cells were plated onto glass coverslips in 12-well plates in
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Figure 15. MDA-MB-231 breast cancer cell lines, which overexpress
p16(INK4A) and p21(WAF1/CIP1), undergo autophagy, and show dramatically reduced tumor growth. (A) Autophagy status. MDA-MB-231 cells,
which overexpress p16(INK4A) and p21(WAF1/CIP1), undergo increased
authophagy, either at baseline (Lamp-1, BNIP3, LC3-I/II) or under conditions of starvation for 12 h with HBSS (Beclin-1 and cathepsin B). (B)
Tumor growth. MDA-MB-231 cells, which overexpress p16(INK4A) and
p21(WAF1/CIP1), show a near 2-fold reduction in tumor volume.

complete media at a cellular ratio of 5:1. The next day, the media
was switched to DMEM supplemented with 10% NuSerum.
Cells were maintained in co-culture for 3 d.
Lenti-virus production and cell line derivation. For lentivirus production, 293Ta cells were transfected with different
plasmids, in particular, EX-neg-Lv105 (the empty vector control),
EX-H0288-Lv105 (encoding p19), EX-T2276-Lv105 (encoding
smARF), EX-T1759-Lv105 (encoding p16) and EX-G0313-Lv105
(encoding p21). All plasmids also contained a puromycin-resistance marker. The resulting lenti-viruses were then used to infect
hTERT fibroblasts or MDA-MB-231-GFP cells to obtain stable
cell lines overexpressing the target gene of interest.
Immunoblot analysis. Immunoblotting was performed on
samples obtained through OG buffer extraction. For this purpose, cells were scraped in OG lyses buffer (10 mM Tris, pH
7.5, 150 mM NaCl, 1% Triton X-100 and 60 mM n-octyl-glucoside), supplemented with a protease-inhibitor cocktail (Roche
Diagnostics) and a phosphatase-inhibitor cocktail (Sigma). The
samples were rotated for 40 min, then centrifuged for 10 min
at 13,000 × g at 4°C. Finally, supernatants were collected. To
determine the expression of cell cycle-related proteins,
the cells were scraped into RIPA buffer (50 mM Tris pH
7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, plus protease-inhibitor and phosphatase-inhibitor cocktails) and sonicated for 20 sec, then
the samples were centrifuge 13,000 × g for 10 min at
4°C, and the supernatants were collected. The protein
concentrations were determined using the BCA protein
assay kit (Thermo scientific, #23225). Protein lysates
were then separated by SDS-PAGE (using a 10-to-15%
acrylamide gel) and transferred to nitrocellulose membranes. To detect expression of the protein of interest,
specific primary antibodies and peroxidase-conjugated
secondary antibodies were used. Bound antibodies were
revealed using enhanced chemiluminescence (ECL)
substrates (Thermo Scientific).
L-lactate assays. L-lactate levels were assessed
according to the manufacturer’s instructions, using the
EnzyChromTM L-Lactate assay kit (cat #ECLC-100,
BioAssay Systems). For this purpose, cells were seeded
Figure 16. Understanding cell cycle arrest, senescence and autophagy: The
sensescence-autophagy transition (SAT). Previously, we showed that recombiin 12-well plates in complete media. The next day, the
nant
expression of autophagy-associated genes (BNIP3, cathepsin B or ATG16L1)
media was switched to DMEM containing 2% FBS.
is sufficient to induce senescence, driving the autophagy-senescence transition
After 48 h, the media was collected, and the concentra(AST). Here, we show that recombinant expression of CDK inhibitors (p16/p19/p21)
tion of L-lactate was measured. Results were normalized
is sufficient to induce autophagy, driving the senescence-autophagy transition
for total cell number.
(SAT). Both SAT and AST result in mitochondrial dysfunction and a metabolic shift
toward glycolysis, “powering down” cells during cell cycle arrest. Thus, cell cycle
β-galactosidase staining assay. β-galactosidase
arrest, autophagy and senescence are all part of the same metabolic program that
activity was also detected by using a Senescence
occurs in response to cellular stress.
β-galactosidase staining kit (Cell Signaling, #9860).

www.landesbioscience.com

Cell Cycle

3607

For this purpose, cells were seeded into 6-well plates in complete
media. After 24 h, the media was changed to DMEM supplemented with 10% Nu-serum. After 48 h, the cells were fixed and
incubated overnight at 37°C in a dry incubator without CO2
with the β-galactosidase Staining solution. Afterwards, cells were
observed under the microscope.
Cellular hypertrophy assay. Approximately 100,000 cells
were seeded per well in 12-well plates in DMEM containing 10%
FBS. The next day, the media was switched to DMEM supplemented with 10% Nu-serum. After 24 h, cells were counted and
protein lysates were prepared with OG buffer. Protein quantification was performed using the BCA protein assay kit (Thermo
scientific, #23225). The values obtained were expressed as a ratio
between the total amount of protein per well and the total number of cells per well (protein/cell number). An increased protein/
cell number ratio would be indicative of cellular hypertrophy.
Animal studies. To evaluate the in vivo tumor-promoting
effects of CDK-inhibitor proteins, flank injections were performed on athymic NCr nude mice (NCRNU; Taconic Farms;
at 6–8 wk of age). Experiments were performed according to the
National Institutes of Health (NIH) guidelines, with the consensus of the Institutional Animal Care and Use Committee
(IACUC) of Thomas Jefferson University. MDA-MB-231-GFP
cells (alone or plus hTERT-fibroblasts) were injected into the
flanks of nude mice. More specifically, MDA-MB-231-GFP cancer cells (1 million cells) plus hTERT-BJ1 fibroblasts (300,000
cells) were re-suspended in 100 μl of sterile PBS, just prior to
co-injection into the flank. After 4 wk post-injection, the tumors
were collected and tumor growth was quantitatively measured.
Quantitation of tumor angiogenesis. Six-μm tumor frozen
sections were fixed with 4% paraformaldehyde in PBS for 10 min
at 4°C and washed 3x with PBS. A three-step biotin-streptavidinhorseradish peroxidase method was used for antibody detection.
After fixation, the sections were blocked with 10% rabbit serum
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